Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Rodolfo Villena, Paula Kriz, Myint Tin Tin Htar, Cindy Burman, Jamie Findlow, Paul Balmer & Luis Jodar. (2023) Real-world impact and effectiveness of MenACWY-TT. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Franco M. Piazza, Miia Virta, Marita Paassilta, Benita Ukkonen, Anitta Ahonen, Alejandra Esteves-Jaramillo, Aino Forsten, Ilkka Seppa, Jian Ding, David Neveu, Emilia Jordanov & Mandeep S. Dhingra. (2022) Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study. Human Vaccines & Immunotherapeutics 18:1, pages 1-10.
Read now
Read now
María Gabriela Graña, Gabriel Cavada, Marjorie Vasquez, Jing Shen, Johan Maervoet, Johan Klint & Jorge A. Gómez. (2021) Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile. Human Vaccines & Immunotherapeutics 17:12, pages 5603-5613.
Read now
Read now
Weichang Luo, Peter D. Arkwright & Ray Borrow. (2020) Antibody persistence following meningococcal ACWY conjugate vaccine licensed in the European Union by age group and vaccine. Expert Review of Vaccines 19:8, pages 745-754.
Read now
Read now
Timo Vesikari, Paula Peyrani, Chris Webber, Marie Van Der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Emmanuel Aris, Mark Cutler, Ping Li & John L. Perez. (2020) Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age. Human Vaccines & Immunotherapeutics 16:6, pages 1280-1291.
Read now
Read now
Jamie Findlow, Paul Balmer & Ray Borrow. (2019) A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines. Human Vaccines & Immunotherapeutics 15:10, pages 2491-2500.
Read now
Read now
Robert G. K. Donald, Julio Cesar Hawkins, Li Hao, Paul Liberator, Thomas R. Jones, Shannon L. Harris, John L. Perez, Joseph J. Eiden, Kathrin U. Jansen & Annaliesa S. Anderson. (2017) Meningococcal serogroup B vaccines: Estimating breadth of coverage. Human Vaccines & Immunotherapeutics 13:2, pages 255-265.
Read now
Read now
Giulia Piccini, Alessandro Torelli, Elena Gianchecchi, Simona Piccirella & Emanuele Montomoli. (2016) Fighting Neisseria meningitidis: past and current vaccination strategies. Expert Review of Vaccines 15:11, pages 1393-1407.
Read now
Read now
Articles from other publishers (14)
Clare L. Cutland, Paula Peyrani, Chris Webber, Ryan Newton, Mark Cutler & John L. Perez. (2023) A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12–14-month-old children. Vaccine 41:5, pages 1153-1160.
Crossref
Crossref
Arianna Neri, Massimo Fabiani, Anna Maria Barbui, Caterina Vocale, Alessandro Miglietta, Cecilia Fazio, Anna Carannante, Annapina Palmieri, Paola Vacca, Luigina Ambrosio & Paola Stefanelli. (2022) Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy. Vaccines 10:5, pages 778.
Crossref
Crossref
David Pace, Charmaine Gauci & Christopher Barbara. (2020) The epidemiology of invasive meningococcal disease and the utility of vaccination in Malta. European Journal of Clinical Microbiology & Infectious Diseases 39:10, pages 1885-1897.
Crossref
Crossref
Chris Webber, Paula Peyrani, Paul Balmer & Lidia Serra. (2020) Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies. Vaccine 38:27, pages 4236-4245.
Crossref
Crossref
Jessica Presa, Jamie Findlow, Jelena Vojicic, Scott Williams & Lidia Serra. (2019) Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review. Infectious Diseases and Therapy 8:3, pages 307-333.
Crossref
Crossref
Terry Nolan, Robert Booy, Helen S. Marshall, Peter Richmond, Michael Nissen, John B. Ziegler, Yaela Baine, Magali Traskine, Archana Jastorff & Marie Van der Wielen. (2019) Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers. Pediatric Infectious Disease Journal 38:6, pages 643-650.
Crossref
Crossref
Jamie Findlow & Markus Knuf. (2019) Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence. Future Microbiology 14:7, pages 563-580.
Crossref
Crossref
Michael L. Jackson, Alpha Oumar Diallo, Isaie Médah, Brice Wilfried Bicaba, Issaka Yaméogo, Daouda Koussoubé, Rasmata Ouédraogo, Lassané Sangaré & Sarah A. Mbaeyi. (2018) Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt. PLOS ONE 13:10, pages e0206117.
Crossref
Crossref
Markus Knuf, Klaus Helm, Devayani Kolhe, Marie Van Der Wielen & Yaela Baine. (2018) Antibody persistence and booster response 68 months after vaccination at 2–10 years of age with one dose of MenACWY-TT conjugate vaccine. Vaccine 36:23, pages 3286-3295.
Crossref
Crossref
Clare L. Cutland, Terry Nolan, Scott A. Halperin, Zafer Kurugol, Khatija Ahmed, Kirsten P. Perrett, Peter Richmond, Helen S Marshall, Mehmet Ceyhan, Devayani Kolhe, Marjan Hezareh & Marie Van Der Wielen. (2018) Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study. Vaccine 36:14, pages 1908-1916.
Crossref
Crossref
Federico Martinón-Torres, Alfonso Carmona Martinez, Róbert Simkó, Pilar Infante Marquez, Josep-Lluis Arimany, Francisco Gimenez-Sanchez, José Antonio Couceiro Gianzo, Éva Kovács, Pablo Rojo, Huajun Wang, Chiranjiwi Bhusal & Daniela Toneatto. (2018) Antibody persistence and booster responses 24–36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial. Journal of Infection 76:3, pages 258-269.
Crossref
Crossref
Sohita Dhillon & David Pace. (2017) Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix®): A Review. Drugs 77:17, pages 1881-1896.
Crossref
Crossref
Jose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, Xavier Maria Perez Porcuna, Maria del Carmen Otero Reigada, Josep Marès Bermúdez, Fernando Centeno Malfaz, Mariano Miranda, Maria Mendez, Miguel Angel Garcia Cabezas, Christoph Wittermann, Gerhard Bleckmann, Thomas Fischbach, Devayani Kolhe, Marie van der Wielen & Yaela Baine. (2017) Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants. Pediatric Infectious Disease Journal 36:4, pages e98-e107.
Crossref
Crossref
Mildred A. Iro, Matthew D. Snape, Merryn Voysey, Sena Jawad, Adam Finn, Paul T. Heath, Gianni Bona, Susanna Esposito, Javier Diez-Domingo, Roman Prymula, Adefowope Odueyungbo, Daniela Toneatto, Peter Dull & Andrew J. Pollard. (2017) Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial. Vaccine 35:2, pages 395-402.
Crossref
Crossref